BASE facility partners with Sartorious to improve mRNA synthesis.


Göttingen, Oct 17, 2022 — Sartorius has entered a research partnership with The BASE Facility at The University of Queensland. This collaboration will leverage BASE’s advanced manufacturing and analytics capabilities, including novel next-generation sequencing approaches to co-develop protocols and methods for mRNA and pDNA production.

“The combination of the Sartorius systems will greatly accelerate the accuracy and speed of tasks of bioprocess optimization to support the BASE facility delivering its mission.” – Andreas Kocourek, Head of General Sales ANZ, Sartorius

“BASE’s partnership with Sartorius will drive innovation in advanced mRNA manufacture. We are delighted to be working closely with a world leader in bioprocessing to enable manufacturing solutions for the medicines of tomorrow.” -Associate Professor Tim Mercer, BASE Director